The hypotheses assumed. Only if the time horizon was set to 8 weeks, there would be an important increase on the incremental cost utility ratio. In fact, for a time horizon of 8 weeks the cost per QALY is 58,093. However, it should be clarified that the time horizon for economic evaluations of drugs is often extended beyond the duration of the clinical trial. This is so because clinical trials are